Choroid Plexus Epithelial Cells In Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Choroid plexus (CP) epithelial cells form the blood-cerebrospinal fluid barrier and are responsible for CSF production. These specialized ependymal cells undergo age-related changes and are affected in various neurodegenerative disorders. CP dysfunction contributes to altered CSF composition, impaired brain clearance, and neuroinflammation in conditions like Alzheimer's disease, Parkinson's disease, and normal pressure hydrocephalus.
The choroid plexus consists of frond-like villi protruding into the ventricles:
- Lateral ventricles: Body and temporal horn
- Third ventricle: Roof
- Fourth ventricle: Roof and lateral recesses
Choroid Plexus Epithelial Cells (CPECs):
- Apical surface: Ciliated, microvilli
- Basal surface: Highly infolded
- Tight junctions: Blood-CSF barrier
- Stromal core: Capillaries, fibroblasts
- Tight junction proteins: Claudin-1, occludin, ZO-1
- Transporters: ABC efflux pumps
- Enzymes: Drug-metabolizing enzymes
- Na+/K+ ATPase: CSF ion composition
- Aquaporin 1: Water transport
- Transthyretin (TTR): Thyroid hormone transport
- Transferrin: Iron transport
- CSF: 400-500 mL/day production
- Growth factors: NGF, BDNF
- Cytokines: Modulatory molecules
- TTR: Most specific marker
- CK18: Cytokeratin
- GFAP: Some expression
- Active transport: Ion pumps
- Ultrafiltration: Plasma-derived fluid
- Secretion: Selective molecular transport
- Tight junctions: Paracellular barrier
- Efflux transporters: Xenobiotic clearance
- Enzymatic activity: Drug metabolism
- CSF circulation: Perivascular influx
- Aβ clearance: Receptor-mediated
- Tau clearance: Less characterized
Pathology:
- CP atrophy: Reduced CSF production
- Barrier dysfunction: Leakage
- Accumulation: Aβ, tau
Functional Changes:
- Reduced TTR: Decreased neuroprotection
- Altered transport: Clearance deficits
- Inflammation: Pro-inflammatory state
- CP iron accumulation: Ferritin increase
- Barrier dysfunction: Permeability changes
- Alpha-synuclein: Possible accumulation
- Impaired CSF dynamics: Primary pathology
- CP morphology: Altered
- Pressure dysregulation: Ventricular enlargement
- Barrier breakdown: Leaky CP
- Immune cell infiltration: CNS entry
- Vitamin D metabolism: Altered
- Morphology: Atrophy, fibrosis
- Function: Reduced CSF production
- Barrier: Increased permeability
- Transport: Decreased function
- Alzheimer's risk: Age-related changes
- Drug delivery: Altered pharmacokinetics
- CSF biomarkers: Background noise
- Intrathecal administration: Bypasses CP
- Nanoparticles: Targeted delivery
- Transient opening: Barrier modulation
- CSF sampling: Reflects CP function
- TTR levels: Disease biomarker
- Albumin ratio: Barrier integrity
- CP regeneration: Stem cell approaches
- Barrier restoration: Tight junction enhancers
- Anti-inflammatory: CP protection
- Aged rodents: Spontaneous changes
- Transgenic models: AD, PD
- Injury models: Barrier disruption
- Primary CP cultures
- iPSC-derived epithelial cells
- Organoid systems
The study of Choroid Plexus Epithelial Cells In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Segal MB. Choroid plexus. Microsc Res Tech. 2001.
- Strazielle N, Ghersi-Egea JF. Choroid plexus. J Neuropathol Exp Neurol. 2000.
- Serot JM, et al. Choroid plexus in aging. J Neural Transm. 2011.
- Marques F, et al. Choroid plexus in AD. Nat Rev Neurosci. 2013.
- Spector R, et al. CSF formation and clearance. J Neurochem. 2015.